Table 5.
DOAC Laboratory Monitoring
Drug Name | Qualitative | Quantitative | Other | ||||||
---|---|---|---|---|---|---|---|---|---|
aPTT | TT | PT | Anti‐FXa Levels | Plasma Drug Concentration | dTT | ECT | CBC | CMP | |
Dabigatran | x | x | x | x | x | x | x | x | |
Rivaroxaban | x | x | x | x | x | ||||
Apixaban | x | x | x | x | x | ||||
Edoxaban | x | x | x | x | x | ||||
Betrixaban | x | x | x | x |
aPTT indicates activated partial thromboplastin time; CBC, complete blood count; CMP, comprehensive metabolic panel; dTT, dilute thrombin time; ECT, ecarin thrombin time; FXa, activated factor X; PT, prothrombin time; and TT, thrombin time.